Heron Therapeutics (HRTX) – Analyst EPS View
-
Heron Therapeutics (HRTX) PT Raised to $30 at Needham & Company
-
Heron Therapeutics (HRTX) PT Lowered to $30 at Cantor Fitzgerald Following $167.3M Capital Raise
-
-
-
Back to HRTX Stock Lookup